Extending Paxlovid to Twenty Five Days Did Not Ease Long COVID Symptoms in a 959 Person Trial

A 959-person NIH trial found that extended Paxlovid did not improve long COVID symptoms versus placebo, testing the lingering virus theory directly.

Have A Referral?